ArticleCancers2022

A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma Patients.

Patrick Terrematte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.